Skip to content
10-Q

Quarterly Report

X4 Pharmaceuticals, Inc XFOR

0001628280-25-039327

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 11.41M sh
Shares Diluted Q2 2025 · Jun 30, 2025 7.41M sh
Shares Diluted Q2 2025 · Jun 30, 2025 7.1M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 6.69M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 6.68M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$42.27M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$63.87M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $39.22M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $55.7M
Stockholders Equity Q2 2025 · Jun 30, 2025 $3.97M
Stockholders Equity Q2 2025 · Mar 31, 2025 $22.94M
Stockholders Equity Q2 2025 · Dec 31, 2024 $22.15M
Stockholders Equity Q2 2025 · Jun 30, 2024 $94.45M
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.04M
Stockholders Equity Q2 2025 · Dec 31, 2023 $51.1M
Current Liabilities Q2 2025 · Jun 30, 2025 $22.9M
Current Liabilities Q2 2025 · Dec 31, 2024 $32.88M
Total Liabilities Q2 2025 · Jun 30, 2025 $101.2M
Total Liabilities Q2 2025 · Dec 31, 2024 $124.3M
Current Assets Q2 2025 · Jun 30, 2025 $72.94M
Current Assets Q2 2025 · Dec 31, 2024 $112.18M
Total Assets Q2 2025 · Jun 30, 2025 $105.17M
Total Assets Q2 2025 · Dec 31, 2024 $146.45M
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.47
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.59
Eps Diluted restated Q2 2025 · Jun 30, 2024 $13.57
Eps Diluted restated Q2 2025 · Jun 30, 2024 $5.85
Eps Basic Q2 2025 · Jun 30, 2025 −$3.47
Eps Basic Q2 2025 · Jun 30, 2025 −$3.59
Eps Basic restated Q2 2025 · Jun 30, 2024 $13.59
Eps Basic restated Q2 2025 · Jun 30, 2024 $5.85
Sga Expense Q2 2025 · Jun 30, 2025 $9.53M
Sga Expense Q2 2025 · Jun 30, 2025 $24.55M
Sga Expense Q2 2025 · Jun 30, 2024 $13.28M
Sga Expense Q2 2025 · Jun 30, 2024 $30.71M
Rd Expense Q2 2025 · Jun 30, 2025 $18.35M
Rd Expense Q2 2025 · Jun 30, 2025 $36.87M
Rd Expense Q2 2025 · Jun 30, 2024 $20.91M
Rd Expense Q2 2025 · Jun 30, 2024 $40.77M
Net Income Q2 2025 · Jun 30, 2025 −$25.74M
Net Income Q2 2025 · Jun 30, 2025 −$25.46M
Net Income Q2 2025 · Mar 31, 2025 $282K
Net Income Q2 2025 · Jun 30, 2024 $90.83M
Net Income Q2 2025 · Jun 30, 2024 $39.07M
Net Income Q2 2025 · Mar 31, 2024 −$51.77M
Operating Income Q2 2025 · Jun 30, 2025 −$26.23M
Operating Income Q2 2025 · Jun 30, 2025 −$35.68M
Operating Income Q2 2025 · Jun 30, 2024 $71.1M
Operating Income Q2 2025 · Jun 30, 2024 $33.81M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $326K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.04M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $268K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $268K
Revenue Q2 2025 · Jun 30, 2025 $1.97M
Revenue Q2 2025 · Jun 30, 2025 $30.78M
Revenue restated Q2 2025 · Jun 30, 2024 $563K
Revenue restated Q2 2025 · Jun 30, 2024 $563K